Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weihang Ji

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Nano Letters|March 15, 2019
Targeted Codelivery of an Antigen and Dual Agonists by Hybrid Nanoparticles for Enhanced Cancer ImmunotherapyLinhua Zhang, Shengjie Wu, Yu Qin, et al.
Current HIV Research|September 15, 2025
Impact of HIV-1 Tat on FDFT1 Suppression, Changes in Cholesterol Level, and KSHV Replication in BCBL1 CellsQiaozhen Liu, Xiaoying Chen, Dewen Liu, et al.
Nature Nanotechnology|April 19, 2017
In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriersTyrel T Smith, Sirkka B Stephan, Howell F Moffett, et al.
Cell Death & Disease|May 30, 2023
Long non-coding RNA KCND1 protects hearts from hypertrophy by targeting YBX1Rui Yang, Liangliang Li, Yumeng Hou, et al.
Biomaterials|November 22, 2016
Magnetic mesoporous nanospheres anchored with LyP-1 as an efficient pancreatic cancer probeYongjian Jiang, Shaojun Liu, Yu Zhang, et al.
Cell Death & Disease|June 6, 2022
Systematic analyses identify the anti-fibrotic role of lncRNA TP53TG1 in IPFJian Sun, Yingying Guo, Tingting Chen, et al.
European Heart Journal|June 5, 2025
Deficiency of the RNA-binding protein RBMS1 improves myocardial fibrosis and heart failureLiangliang Li, Jiayu Guo, Jiayue Feng, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Nano Letters|March 15, 2019
Targeted Codelivery of an Antigen and Dual Agonists by Hybrid Nanoparticles for Enhanced Cancer ImmunotherapyLinhua Zhang, Shengjie Wu, Yu Qin, et al.
Current HIV Research|September 15, 2025
Impact of HIV-1 Tat on FDFT1 Suppression, Changes in Cholesterol Level, and KSHV Replication in BCBL1 CellsQiaozhen Liu, Xiaoying Chen, Dewen Liu, et al.
Nature Nanotechnology|April 19, 2017
In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriersTyrel T Smith, Sirkka B Stephan, Howell F Moffett, et al.
Cell Death & Disease|May 30, 2023
Long non-coding RNA KCND1 protects hearts from hypertrophy by targeting YBX1Rui Yang, Liangliang Li, Yumeng Hou, et al.
Biomaterials|November 22, 2016
Magnetic mesoporous nanospheres anchored with LyP-1 as an efficient pancreatic cancer probeYongjian Jiang, Shaojun Liu, Yu Zhang, et al.
Cell Death & Disease|June 6, 2022
Systematic analyses identify the anti-fibrotic role of lncRNA TP53TG1 in IPFJian Sun, Yingying Guo, Tingting Chen, et al.
European Heart Journal|June 5, 2025
Deficiency of the RNA-binding protein RBMS1 improves myocardial fibrosis and heart failureLiangliang Li, Jiayu Guo, Jiayue Feng, et al.
Pageof 3